|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Best Practice
Open Access
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Form
Ethics Disclosure form
All issues
Ahead-of Print Articles
Most Read Articles
Most Cited Articles
Radiation Oncology Journal
Search
Author Index
Radiation Oncology Journal
Search
> Browse Articles > Search
Hyperfractionated Radiotherapy and Concurrent Chemotherapy for Stage III Unreasectabel Non Small Cell Lung Cancer: Preliminary Report for Response and Toxicity
Eun Kyung Choi, Jong Hoon Kim, Hyesook Chang, Sang We Kim, Cheolwon Suh, Kyoo Hyung Lee, Jung Shin Lee, Sang Hee Kim, Youn Suk Ko, Woo Sung Kim, Dong Soon Kim, Won Dong Kim, Koun Sik Song, Seung Il Park, Kwang Hyun Sohn
J Korean Soc Ther Radiol.
1995;13(2):157-162.
PDF
Postoperative adjuvant MVP Chemotherapy and Radiotherapy for Non-Small Cell Lung Cancer
Jong Hoon Kim, Eun Kyung Choi, Hye Sook Chang, Sang Wee Kim, Chul Won Suh, Kyoo Hyung Lee, Jung Shin Lee, Sang Hee Kim, Woo Sung Kim, Dong Soon Kim, Won Dong Kim, Seung Il Park, Kwang Hyun Sohn
J Korean Soc Ther Radiol.
1995;13(2):149-156.
PDF
Hyperfractionated Radiotherapy Following Induction Chemotherapy for Stage III Non-Small Cell Lung Cancer: Random iced for Adjuvant Chemotherapy vs. Observation
Eun Kyung Choi, Hye Sook Chang, Seung Do Ahn, Kwang Mo Yang, Cheol Won Suh, Kyoo Hyung Lee, Jung Shin Lee, Sang Hee Kim, Youn Suk Ko, Woo Sung Kim, Won Dong Kim, Koun Sik Song, Kwang Hyun Sohn
J Korean Soc Ther Radiol.
1993;11(2):295-302.
PDF
MVP Chemotherpy and Hyperfractionated Radiotherapy for Stage III Unresectable Non-Small Cell Lung Cancer: Randomized for maintenance Chemotherapy vs. Observation: Preliminary Report
Euk Kyung Choi, Hyesook Chang, Cheolwon Suh, Kyoo Hyung Lee, Jung Shin Lee, Sang Hee Kim, Chul Joon Choi, Youn Suck Koh, Woo Sung Kim, Won Dong Kim, Sam Hyun Kim, Kwang Hyun Sohn
J Korean Soc Ther Radiol.
1991;9(2):215-220.
PDF
1
|
Journal Impact Factor 1.8